Free Shipping on purchases over €100

Avène Anti-Ageing Sunscreen Spf 50+ Coloured Face Shield, 3 x 50 ml

Avene Solar Antiageing Colour SPF 50+ provides comprehensive care for sensitive skin, protecting it from the adverse effects of solar radiation. Moisturises and prevents the signs of cellular photodamage. Helps to attenuate blemishes and scars.

 

Contains 3 x 50 ml.

SKU: AV4202601271087
-36%
54.40
€84.90

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

 

Avene Solar Anti-Ageing is a tinted facial sunscreen that evens skin tone, thanks to its reflective pigments. It helps to delay ageing. Its main active ingredients include ascofiline, an active ingredient that makes it possible to restructure and increase collagen synthesis, helping to reduce expression lines and wrinkles. It favours the prevention of the ageing process. Contains Avène thermal spring water, which helps to soothe and calm sensitive skin. It has a balanced system of four sun filters for UVB-UVA protection, highly water-resistant and maximum skin tolerance.

 

Pretocoferi is a precursor of Vitamin E and acts as an antioxidant and protector against oxidative damage from free radicals. Reflective pigments and photostable vitamin C balance skin tone, helping to correct and attenuate the appearance of skin blemishes, residual marks or scars. This cream provides enhanced daily sun protection. It is ideal for dry and delicate facial skin. Thanks to its silky and melting texture, it moisturises the skin for 8 hours, providing nourishment and softness to the touch. Its natural tone makes it easy to adapt to most skin tones and evens out the complexion on a daily basis. It is therefore an excellent make-up base.

 

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.